Deadline for submitting an abstract has now passed
Thank you to everyone who submitted an abstract for the 37th International Symposium on ALS/MND.
Abstract status: under review
Please note
- Abstract decision emails will be sent out w/c 10 August to oral speakers followed by poster presenters.
- Presenting authors are expected to register and accept abstract decision for the Symposium before 4 September 2026 to secure attendance. Failure to register without prior contact may result in your abstract being withdrawn.
- Poster presenters will be given further instructions on how to submit poster material (PDF) from September.
- Refunds can be made available in the event that you no longer wish to attend due to an abstract being rejected. Please see Symposium registration T&Cs for more information.
Presenter registration
If you have submitted an abstract, please use the registration link within the abstract portal below by 4 September 2026.
Failure to register by 4 September may result in your abstract being withdrawn
Key dates
| Notification of abstract decision | August 2026 |
| Withdrawal deadline | 4 September 2026 (23:59 UK time) |
| Poster submission (PDF) opens | September 2026 |
| Poster submission (PDF) deadline | mid-November 2026 (23:59 UK time) |
| Abstract book published on website | November 2026 |
| Symposium | 9–11 December 2026 |
You can sign up for regular Symposium updates by contacting symposium@mndassociation.org so that you don't miss any important dates and announcements.
If you have any specific abstract-related queries, please contact abstracts@mndassociation.org.
Abstract submission information and FAQs
Authors will be asked to assign a theme to their abstract in the abstract submission portal. The themes are as follows:
- Epidemiology and Informatics (EPI)
- Genetics and genomics (GEN)
- In vitro experimental models (IVT)
- In vivo experimental models (IVV)
- Human cell biology and pathology (HCB)
- Tissue biomarkers (BIO)
- Pre-clinical therapeutic strategies (TST)
- Clinical imaging and electrophysiology (IMG)
- Clinical trials and trial design (CLT)
- Disease stratification and phenotyping of patients (DSP)
- Cognitive and psychological assessment and support (COG)
- Clinical management and support (CMS)
- Primary lateral sclerosis and upper motor neurone degeneration (PLS)
Submissions are limited to two abstracts per presenting author.
Authors do not need to register before submitting an abstract however we do recommend registering and applying for a VISA as early as possible. Refunds will be available in the event of an abstract being rejected.
Presenting authors will be required to pay the appropriate in-person registration fee by 5 September or their abstract will be withdrawn. Formal acceptance of an abstract is conditional upon payment of the full registration fee.
Abstracts will be published in an online open access supplement of Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. This abstract book will be published online on the Taylor and Francis website and will be found via the Symposium website (symposium.mndassociation.org). Abstracts accepted as ‘WIP/CP’ will be published on the MND Association’s Symposium website.
By submitting an abstract, you consent to give us the license to act on your behalf with the Taylor & Francis group to publish your abstract in the symposium supplement of Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration.
WIP/CP stands for work in progress/care practice. WIP/CP is defined as: preliminary work (little or no data/results), care practice or case studies.
Yes, abstracts may be submitted even if previously presented at a national/international meeting.
Once the submission deadline has passed, abstracts will be reviewed by the Symposium Programme Committee. We will inform you of the decision in late August and if you have been accepted. This will be followed by a second notification in September which will include specific presentation theme/session, time and date information. Poster presenters will also receive details and instructions on poster guidelines and how to submit their poster material (poster PDF) to our virtual platform for our virtual delegates before the upload deadline of 17 November 2025.
The review committee will first review your abstract and select the oral talks from those listed, any not selected may be offered a poster presentation instead.